NCT07637305

Brief Summary

This pilot randomized clinical study aims to compare bacterial profiles in symptomatic and asymptomatic primary apical periodontitis using 16S rRNA polymerase chain reaction sequencing. Twenty-four mandibular first molars requiring endodontic treatment will be selected from patients attending the Conservative Dentistry Clinic at the Dental and Oral Hospital of Hasanuddin University. The samples will be divided into two diagnostic groups: symptomatic primary apical periodontitis and asymptomatic primary apical periodontitis. Each diagnostic group will then be allocated into two irrigation groups using either 3% or 5.25% sodium hypochlorite. Microbial samples will be collected from the distal root canal at three time points: before root canal treatment, after chemomechanical preparation and sodium hypochlorite irrigation with ultrasonic activation, and two weeks after intracanal calcium hydroxide medication. Root canal samples will be subjected to bacterial DNA extraction, 16S rRNA PCR amplification, sequencing, and taxonomic identification. The primary outcome is the presence or absence of detectable bacterial DNA at each sampling stage. Secondary outcomes include the bacterial taxa identified in symptomatic and asymptomatic primary apical periodontitis and changes in bacterial profiles after sodium hypochlorite irrigation and calcium hydroxide medication. The study is designed to provide preliminary clinical-molecular evidence on bacterial profile changes during endodontic treatment of primary apical periodontitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 13, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 9, 2026

Completed
Last Updated

June 9, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

June 4, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

Periapical PeriodontitisRoot canal infectionSodium HypochloriteCalcium HydroxidePolymerase Chain ReactionRNA, Ribosomal, 16SDNA, BacterialMolecular Diagnostic Techniques

Outcome Measures

Primary Outcomes (1)

  • Detection of Bacterial DNA in Root Canal Samples

    The presence or absence of detectable bacterial DNA will be assessed using 16S rRNA PCR sequencing in distal root canal samples collected before treatment, after sodium hypochlorite irrigation with ultrasonic activation, and two weeks after intracanal calcium hydroxide medication.

    Baseline, immediately after irrigation, and 2 weeks after intracanal calcium hydroxide medication

Secondary Outcomes (1)

  • Bacterial Profile Changes During Endodontic Treatment

    Baseline, immediately after irrigation, and 2 weeks after intracanal calcium hydroxide medication

Study Arms (4)

Symptomatic Apical Periodontitis with 3% Sodium Hypochlorite

EXPERIMENTAL

Participants with mandibular first molars diagnosed with symptomatic primary apical periodontitis will receive root canal treatment with 3% sodium hypochlorite irrigation.

Drug: 3% Sodium Hypochlorite Irrigation with Ultrasonic Activation

Symptomatic Apical Periodontitis with 5.25% Sodium Hypochlorite

EXPERIMENTAL

Participants with mandibular first molars diagnosed with symptomatic primary apical periodontitis will receive root canal treatment with 5.25% sodium hypochlorite irrigation.

Drug: 5.25% Sodium Hypochlorite Irrigation with Ultrasonic Activation

Asymptomatic Apical Periodontitis with 3% Sodium Hypochlorite

EXPERIMENTAL

Participants with mandibular first molars diagnosed with asymptomatic primary apical periodontitis will receive root canal treatment with 3% sodium hypochlorite irrigation.

Drug: 3% Sodium Hypochlorite Irrigation with Ultrasonic Activation

Asymptomatic Apical Periodontitis with 5.25% Sodium Hypochlorite

EXPERIMENTAL

Participants with mandibular first molars diagnosed with asymptomatic primary apical periodontitis will receive root canal treatment with 5.25% sodium hypochlorite irrigation.

Drug: 5.25% Sodium Hypochlorite Irrigation with Ultrasonic Activation

Interventions

Root canals will be prepared using rotary ProTaper Gold instruments up to F2. Irrigation will be performed using 5.25% sodium hypochlorite, followed by sterile distilled water, 17% EDTA, and sterile distilled water. The irrigant will be activated ultrasonically for 20 seconds per cycle for three cycles. Microbial samples will be collected before treatment, after irrigation, and two weeks after calcium hydroxide intracanal medication.

Asymptomatic Apical Periodontitis with 5.25% Sodium HypochloriteSymptomatic Apical Periodontitis with 5.25% Sodium Hypochlorite

Root canals will be prepared using rotary ProTaper Gold instruments up to F2. Irrigation will be performed using 3% sodium hypochlorite, followed by sterile distilled water, 17% EDTA, and sterile distilled water. The irrigant will be activated ultrasonically for 20 seconds per cycle for three cycles. Microbial samples will be collected before treatment, after irrigation, and two weeks after calcium hydroxide intracanal medication.

Asymptomatic Apical Periodontitis with 3% Sodium HypochloriteSymptomatic Apical Periodontitis with 3% Sodium Hypochlorite

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients who are mentally and physically healthy, aged 18-40 years.
  • Mature permanent molar teeth diagnosed with symptomatic or asymptomatic apical periodontitis, determined based on:
  • Patient history; Intraoral clinical examination; For symptomatic apical periodontitis: negative pulp vitality test, negative palpation test, positive percussion test, with or without widening of the periodontal ligament space; For asymptomatic apical periodontitis: negative pulp vitality test, negative palpation test, percussion test findings, and radiographic assessment using a periapical index score of less than 5 based on periapical radiographs.
  • Teeth with straight root canals. Teeth that are restorable after root canal treatment. Patients who are willing to participate in the study and have signed the informed consent form after receiving an explanation of the study.

You may not qualify if:

  • Participants will be excluded if the tooth or patient presents with any of the following conditions:
  • Patients who have taken antibiotics within 7 days before sample collection. Advanced tooth mobility greater than grade 2. Periodontal pockets greater than 4 mm. Teeth with previous endodontic treatment. Root fracture or fracture occurring during root canal treatment. Teeth showing internal or external resorption. Teeth with open apices. Teeth with calcified or obliterated root canals. Patients with systemically compromised conditions requiring antibiotic coverage for routine dental treatment or patients with systemic diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental and Oral Hospital of Hasanuddin University

Makassar, South Sulawesi, 90245, Indonesia

Location

Related Publications (2)

  • Alquria TA, Acharya A, Tordik P, Griffin I, Martinho FC. Impact of root canal disinfection on the bacteriome present in primary endodontic infection: A next generation sequencing study. Int Endod J. 2024 Aug;57(8):1124-1135. doi: 10.1111/iej.14074. Epub 2024 May 3.

    PMID: 38700876BACKGROUND
  • Siqueira JF Jr, Rocas IN. Present status and future directions: Microbiology of endodontic infections. Int Endod J. 2022 May;55 Suppl 3:512-530. doi: 10.1111/iej.13677. Epub 2022 Jan 13.

MeSH Terms

Conditions

Periapical Periodontitis

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • Juwita Purnamasari, DDS

    Dental and Oral Hospital Hasanuddin University, Makassar, South Sulawesi, Indonesia, 90245

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The allocation of sodium hypochlorite concentration will be performed randomly by a dental nurse and will not be known by the researcher during sample allocation. No participant masking is applied.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants with mandibular first molars diagnosed with symptomatic or asymptomatic primary apical periodontitis will be assigned to receive root canal irrigation using either 3% sodium hypochlorite or 5.25% sodium hypochlorite during endodontic treatment. Microbial samples will be collected from the distal root canal before treatment, after chemomechanical preparation and sodium hypochlorite irrigation with ultrasonic activation, and two weeks after intracanal calcium hydroxide medication. Bacterial profiles will be identified using 16S rRNA polymerase chain reaction sequencing.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Endodontic Resident

Study Record Dates

First Submitted

June 4, 2026

First Posted

June 9, 2026

Study Start

October 13, 2025

Primary Completion

February 28, 2026

Study Completion

March 31, 2026

Last Updated

June 9, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

The IPD will not be shared because the researchers have guaranteed the confidentiality of patient data

Locations